These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4801442)

  • 1. [Proceedings: Estrogen over or undersupply in hormonal contraception?].
    Schwartz U; Hammerstein J
    Arch Gynakol; 1973 Sep; 214(1):255-6. PubMed ID: 4801442
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of oral contraceptives on human endometrium in culture.
    Csermely T; Hughes EC; Demers LM
    Am J Obstet Gynecol; 1971 Apr; 109(7):1066-72. PubMed ID: 4101599
    [No Abstract]   [Full Text] [Related]  

  • 3. The oestrogenic potency of various contraceptive steroids as determined by their effects on transcortin-binding capacity.
    Schwartz U; Hammerstein J
    Acta Endocrinol (Copenh); 1974 May; 76(1):159-71. PubMed ID: 4406579
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of various steroids on the vaginal histology in the rat.
    Jones RC; Edgren RA
    Fertil Steril; 1973 Apr; 24(4):284-91. PubMed ID: 4694503
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in plasma lipids caused by oral contraceptives].
    Kaffarnik H
    Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:67-72. PubMed ID: 4114609
    [No Abstract]   [Full Text] [Related]  

  • 8. Estrogen potency of oral contraceptive pills.
    Chihal HJ; Peppler RD; Dickey RP
    Am J Obstet Gynecol; 1975 Jan; 121(1):75-83. PubMed ID: 1115120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitors of ovulation as inhibitors of proliferation].
    Kaiser R
    Geburtshilfe Frauenheilkd; 1973 Jan; 33(1):23-7. PubMed ID: 4119488
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic influence of oral contraceptives.
    Anberg A
    Acta Obstet Gynecol Scand; 1966; 45(S9):40. PubMed ID: 5958395
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver metabolism and contraceptive steroids.
    Brohult J; Westgren A
    Acta Obstet Gynecol Scand; 1966; 45(S9):38-9. PubMed ID: 5958394
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some effects of oral contraceptives on serum-lipid and lipoprotein levels.
    Wynn JW; Doar JW; Mills GL
    Lancet; 1966 Oct; 2(7466):720-3. PubMed ID: 4162056
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of oral contraceptives on glucuronyl transferase.
    Hargreaves T; Piper RF; Cam J
    Nat New Biol; 1971 Nov; 234(47):110-1. PubMed ID: 5289221
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of some steroids in oral contraceptives on the cleavage of rabbit eggs in vitro.
    Daniel JC; Cowan ML
    J Endocrinol; 1966 Jun; 35(2):155-60. PubMed ID: 5950221
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of oral contraceptives on ascorbic acid concentrations in healthy, sexually mature women.
    McLeroy VJ; Schendel HE
    Am J Clin Nutr; 1973 Feb; 26(2):191-6. PubMed ID: 4122161
    [No Abstract]   [Full Text] [Related]  

  • 17. An in vivo system in man for quantitation of estrogenicity. II. Pharmacologic changes in binding capacity of serum corticosteroid-binding globulin induced by conjugated estrogens, mestranol, and ethinyl estradiol.
    Moore DE; Kawagoe S; Davajan V; Nakamura RM; Mishell DR
    Am J Obstet Gynecol; 1978 Feb; 130(4):482-6. PubMed ID: 204191
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma renin activity and aldosterone excretion rate in normal subjects. II. Effect of oral contraceptive agents.
    Crane MG; Harris JJ
    J Clin Endocrinol Metab; 1969 Apr; 29(4):558-62. PubMed ID: 5779248
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes of the endometrium during oral hormonal contraception with ethinyl estradiol sulfonate and norethisterone acetate or d-noregestrel].
    Büttner HH; Göretzlehner G; Rudolf K
    Zentralbl Gynakol; 1976; 98(15):914-8. PubMed ID: 970000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcortin as an indicator of estrogenic potency in oral contraceptives.
    Carol W; Börner A; Klinger G; Greinke C
    Endokrinologie; 1980 Mar; 75(2):167-72. PubMed ID: 6156820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.